Search Results 1861-1870 of 15589 for Orange Peel tea

1. A Study To Evaluate PRM-151 In Patients With Idiopathic Pulmonary Fibrosis - Mayo Clinic

   History of a malignancy within the 5 years prior to screening, with the exception of basal cell or squamous cell skin neoplasms. In addition, a malignant ...

2. Study Of Safety And Efficacy Of Dapagliflozin + Metformin XR Versus Metformin XR In Participants With HR+, HER2-, Advanced Breast Cancer While On Treatment With Alpelisib And Fulvestrant - Mayo Clinic

   ... skin cancer or curatively resected cervical cancer. Participants with previously untreated central nervous system (CNS) involvement are ineligible for this ...

3. Bortezomib, Rituximab, and Dexamethasone with or without Temsirolimus in Treating Patients with Untreated or Relapsed Waldenstrom Macroglobulinemia or Relapsed or Refractory Mantle Cell or Follicular Lymphoma - Mayo Clinic

   Bortezomib may also stop the growth of cancer cells by blocking blood flow to the tumor. Monoclonal antibodies, such as rituximab, can block cancer growth in ...

4. Carboplatin And Paclitaxel With Or Without Atezolizumab Before Surgery In Treating Patients With Newly Diagnosed, Stage II-III Triple-Negative Breast Cancer - Mayo Clinic

   Monoclonal antibodies, such as atezolizumab, may block tumor growth in different ways by targeting certain cells. Drugs used in chemotherapy, such as ...

5. Nab-Paclitaxel And Bevacizumab In Treating Patients With Unresectable Stage IV Melanoma Or Gynecological Cancers - Mayo Clinic

   Drugs used in chemotherapy, such as paclitaxel albumin-stabilized nanoparticle formulation, work in different ways to stop the growth of tumor cells, either by ...

6. Midostaurin And Decitabine In Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia And FLT3 Mutation - Mayo Clinic

   This phase II trial studies how well midostaurin and decitabine work in treating older patients with newly diagnosed acute myeloid leukemia and fms-related ...

7. Tamoxifen Citrate, Letrozole, Anastrozole, Or Exemestane With Or Without Chemotherapy In Treating Patients With Invasive RxPONDER Breast Cancer - Mayo Clinic

   No other prior malignancy is allowed except for adequately treated basal cell (or squamous cell) skin cancer, in situ cervical cancer, or other cancer for ...

8. Phase 1 Study To Evaluate MEDI4736 In Subjects With Myelodysplastic Syndrome - Mayo Clinic

   About this study. This is a multicenter, open-label, Phase 1 study to assess the safety and antitumor activity of MEDI4736 as Monotherapy or in Combination ...

9. Study Comparing CB-839 With Cabozantinib Vs. Cabozantinib With Placebo In Patients With Metastatic Renal Cell Carcinoma - Mayo Clinic

   Adequately treated basal cell or squamous cell skin cancer;; Carcinoma in situ of the cervix;; Other neoplasm that, in the opinion of the Principal ...

10. Testing The Addition Of M3814 (Peposertib) To Radiation Therapy For Patients With Advanced Head And Neck Cancer Who Cannot Take Cisplatin - Mayo Clinic

    ... skin cancer carcinoma, in situ of the breast, oral cavity, or cervix, low or very low-risk prostate cancer) unless disease free for a minimum of 3 years ...